Medical artificial intelligence advancements

Artificial intelligence is seeing expanded applications across various medical specialties, ranging from diagnostic imaging to clinical pharmacy and oncology.

In radiology, new musculoskeletal AI solutions are being introduced to analyze bone age, osteoarthritis, scoliosis, and fractures. One specific knee osteoarthritis solution is being integrated into official review processes for health insurance assessment. Additionally, new software is being developed to automatically evaluate the progression of ankylosing spondylitis via X-ray analysis.

In pharmacy, generative AI systems are being utilized to integrate medical databases, significantly reducing the time required for literature searches and multi-drug dose comparisons.

Further developments in cardiology suggest AI is acting as a “copilot” for physicians by enhancing ECG interpretation and echocardiography. While experts note that ultimate medical responsibility remains with humans, AI is also being applied in oncology to analyze skin lesions and improve the accuracy of mammograms and scans for prostate, breast, and lung cancers.

Recent advancements highlight AI’s ability to identify subtle patterns in medical images, such as mammographies or CT scans, that may indicate future cancer risks even when current results appear normal. This capability is noted as particularly significant for early detection in regions like Chile. Technology leaders suggest AI may eventually solve complex biological problems exceeding human capacity, such as modeling how DNA markers are affected by cancer. While systems like the UK’s NHS already utilize AI for administrative tasks and rapid diagnostics, widespread implementation remains dependent on overcoming infrastructure challenges and the need for massive computing power.